Susquehanna International Group, LLP Kezar Life Sciences, Inc. Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 289,719 shares of KZR stock, worth $156,448. This represents 0.0% of its overall portfolio holdings.

Number of Shares
289,719
Previous 53,316 443.4%
Holding current value
$156,448
Previous $47,000 268.09%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024
BUY
$0.6 - $0.92 $141,841 - $217,490
236,403 Added 443.4%
289,719 $173,000
Q1 2024

May 07, 2024
SELL
$0.8 - $1.05 $25,672 - $33,695
-32,091 Reduced 37.57%
53,316 $47,000
Q4 2023

Feb 14, 2024
BUY
$0.72 - $1.15 $21,299 - $34,020
29,583 Added 52.99%
85,407 $81,000
Q3 2023

Nov 14, 2023
SELL
$1.08 - $2.54 $23,637 - $55,592
-21,887 Reduced 28.16%
55,824 $66,000
Q2 2023

Aug 11, 2023
SELL
$2.31 - $3.06 $242,559 - $321,312
-105,004 Reduced 57.47%
77,711 $190,000
Q1 2023

May 16, 2023
BUY
$3.13 - $7.31 $461,027 - $1.08 Million
147,293 Added 415.82%
182,715 $571,000
Q4 2022

Feb 14, 2023
SELL
$6.39 - $8.8 $365,469 - $503,307
-57,194 Reduced 61.75%
35,422 $249,000
Q3 2022

Nov 14, 2022
SELL
$7.99 - $10.75 $146,217 - $196,725
-18,300 Reduced 16.5%
92,616 $797,000
Q2 2022

Aug 15, 2022
BUY
$4.58 - $17.13 $205,683 - $769,291
44,909 Added 68.04%
110,916 $917,000
Q1 2022

May 16, 2022
BUY
$12.3 - $18.33 $162,704 - $242,469
13,228 Added 25.06%
66,007 $1.1 Million
Q4 2021

Feb 14, 2022
BUY
$7.44 - $16.72 $392,675 - $882,464
52,779 New
52,779 $882,000
Q2 2021

Aug 11, 2021
SELL
$4.93 - $6.46 $149,876 - $196,390
-30,401 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$5.24 - $6.99 $79,999 - $106,716
15,267 Added 100.88%
30,401 $181,000
Q4 2020

Feb 16, 2021
SELL
$4.77 - $6.58 $6,840 - $9,435
-1,434 Reduced 8.66%
15,134 $79,000
Q3 2020

Nov 16, 2020
BUY
$4.36 - $5.5 $22,811 - $28,776
5,232 Added 46.15%
16,568 $80,000
Q1 2020

May 15, 2020
BUY
$2.77 - $5.75 $31,400 - $65,182
11,336 New
11,336 $49,000

Others Institutions Holding KZR

# of Institutions
83
Shares Held
39.6M
Call Options Held
3.2K
Put Options Held
700
View Full List

About Kezar Life Sciences, Inc.

KZR Quotes by TradingView
  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $36.9M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email